The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mycoplasma Testing in Clinical Market Research Report 2024
Synopsis
This report studies the Mycoplasma Testing in Clinical, the only way to confirm mycoplasma contamination is by routine testing using one or more special techniques, including direct growth on broth/agar, specific DNA staining, PCR, ELISA, RNA labeling and enzymatic procedures.
The global Mycoplasma Testing in Clinical market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Mycoplasma Testing in Clinical is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mycoplasma Testing in Clinical is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Mycoplasma Testing in Clinical in Cell Line Testing is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Mycoplasma Testing in Clinical include Sartorius AG, MERCK KGAA, ELITechGROUP, Bio-Rad Laboratories, Inc., Eurofins Scientific, Minerva Biolabs, Charles River, Clongen Laboratories and BioFire Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mycoplasma Testing in Clinical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycoplasma Testing in Clinical.
Report Scope
The Mycoplasma Testing in Clinical market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mycoplasma Testing in Clinical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycoplasma Testing in Clinical companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sartorius AG
MERCK KGAA
ELITechGROUP
Bio-Rad Laboratories, Inc.
Eurofins Scientific
Minerva Biolabs
Charles River
Clongen Laboratories
BioFire Diagnostics
PromoCell GmbH
Lonza
Roche
Agilent Technologies, Inc.
Liofilchem Srl
ZEAKON Diagnostics
Segment by Type
PCR
ELSA
Enzymatic Methods
DNA Staining
Segment by Application
Cell Line Testing
Virus Testing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycoplasma Testing in Clinical companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
This report studies the Mycoplasma Testing in Clinical, the only way to confirm mycoplasma contamination is by routine testing using one or more special techniques, including direct growth on broth/agar, specific DNA staining, PCR, ELISA, RNA labeling and enzymatic procedures.
The global Mycoplasma Testing in Clinical market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Mycoplasma Testing in Clinical is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mycoplasma Testing in Clinical is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Mycoplasma Testing in Clinical in Cell Line Testing is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Mycoplasma Testing in Clinical include Sartorius AG, MERCK KGAA, ELITechGROUP, Bio-Rad Laboratories, Inc., Eurofins Scientific, Minerva Biolabs, Charles River, Clongen Laboratories and BioFire Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mycoplasma Testing in Clinical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycoplasma Testing in Clinical.
Report Scope
The Mycoplasma Testing in Clinical market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mycoplasma Testing in Clinical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycoplasma Testing in Clinical companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sartorius AG
MERCK KGAA
ELITechGROUP
Bio-Rad Laboratories, Inc.
Eurofins Scientific
Minerva Biolabs
Charles River
Clongen Laboratories
BioFire Diagnostics
PromoCell GmbH
Lonza
Roche
Agilent Technologies, Inc.
Liofilchem Srl
ZEAKON Diagnostics
Segment by Type
PCR
ELSA
Enzymatic Methods
DNA Staining
Segment by Application
Cell Line Testing
Virus Testing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycoplasma Testing in Clinical companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mycoplasma Testing in Clinical Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 ELSA
1.2.4 Enzymatic Methods
1.2.5 DNA Staining
1.3 Market by Application
1.3.1 Global Mycoplasma Testing in Clinical Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cell Line Testing
1.3.3 Virus Testing
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mycoplasma Testing in Clinical Market Perspective (2019-2030)
2.2 Mycoplasma Testing in Clinical Growth Trends by Region
2.2.1 Global Mycoplasma Testing in Clinical Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mycoplasma Testing in Clinical Historic Market Size by Region (2019-2024)
2.2.3 Mycoplasma Testing in Clinical Forecasted Market Size by Region (2025-2030)
2.3 Mycoplasma Testing in Clinical Market Dynamics
2.3.1 Mycoplasma Testing in Clinical Industry Trends
2.3.2 Mycoplasma Testing in Clinical Market Drivers
2.3.3 Mycoplasma Testing in Clinical Market Challenges
2.3.4 Mycoplasma Testing in Clinical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mycoplasma Testing in Clinical Players by Revenue
3.1.1 Global Top Mycoplasma Testing in Clinical Players by Revenue (2019-2024)
3.1.2 Global Mycoplasma Testing in Clinical Revenue Market Share by Players (2019-2024)
3.2 Global Mycoplasma Testing in Clinical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mycoplasma Testing in Clinical Revenue
3.4 Global Mycoplasma Testing in Clinical Market Concentration Ratio
3.4.1 Global Mycoplasma Testing in Clinical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mycoplasma Testing in Clinical Revenue in 2023
3.5 Mycoplasma Testing in Clinical Key Players Head office and Area Served
3.6 Key Players Mycoplasma Testing in Clinical Product Solution and Service
3.7 Date of Enter into Mycoplasma Testing in Clinical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mycoplasma Testing in Clinical Breakdown Data by Type
4.1 Global Mycoplasma Testing in Clinical Historic Market Size by Type (2019-2024)
4.2 Global Mycoplasma Testing in Clinical Forecasted Market Size by Type (2025-2030)
5 Mycoplasma Testing in Clinical Breakdown Data by Application
5.1 Global Mycoplasma Testing in Clinical Historic Market Size by Application (2019-2024)
5.2 Global Mycoplasma Testing in Clinical Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Mycoplasma Testing in Clinical Market Size (2019-2030)
6.2 North America Mycoplasma Testing in Clinical Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Mycoplasma Testing in Clinical Market Size by Country (2019-2024)
6.4 North America Mycoplasma Testing in Clinical Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mycoplasma Testing in Clinical Market Size (2019-2030)
7.2 Europe Mycoplasma Testing in Clinical Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Mycoplasma Testing in Clinical Market Size by Country (2019-2024)
7.4 Europe Mycoplasma Testing in Clinical Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mycoplasma Testing in Clinical Market Size (2019-2030)
8.2 Asia-Pacific Mycoplasma Testing in Clinical Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Mycoplasma Testing in Clinical Market Size by Region (2019-2024)
8.4 Asia-Pacific Mycoplasma Testing in Clinical Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mycoplasma Testing in Clinical Market Size (2019-2030)
9.2 Latin America Mycoplasma Testing in Clinical Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Mycoplasma Testing in Clinical Market Size by Country (2019-2024)
9.4 Latin America Mycoplasma Testing in Clinical Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mycoplasma Testing in Clinical Market Size (2019-2030)
10.2 Middle East & Africa Mycoplasma Testing in Clinical Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Mycoplasma Testing in Clinical Market Size by Country (2019-2024)
10.4 Middle East & Africa Mycoplasma Testing in Clinical Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sartorius AG
11.1.1 Sartorius AG Company Detail
11.1.2 Sartorius AG Business Overview
11.1.3 Sartorius AG Mycoplasma Testing in Clinical Introduction
11.1.4 Sartorius AG Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.1.5 Sartorius AG Recent Development
11.2 MERCK KGAA
11.2.1 MERCK KGAA Company Detail
11.2.2 MERCK KGAA Business Overview
11.2.3 MERCK KGAA Mycoplasma Testing in Clinical Introduction
11.2.4 MERCK KGAA Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.2.5 MERCK KGAA Recent Development
11.3 ELITechGROUP
11.3.1 ELITechGROUP Company Detail
11.3.2 ELITechGROUP Business Overview
11.3.3 ELITechGROUP Mycoplasma Testing in Clinical Introduction
11.3.4 ELITechGROUP Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.3.5 ELITechGROUP Recent Development
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Bio-Rad Laboratories, Inc. Company Detail
11.4.2 Bio-Rad Laboratories, Inc. Business Overview
11.4.3 Bio-Rad Laboratories, Inc. Mycoplasma Testing in Clinical Introduction
11.4.4 Bio-Rad Laboratories, Inc. Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.4.5 Bio-Rad Laboratories, Inc. Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Detail
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Mycoplasma Testing in Clinical Introduction
11.5.4 Eurofins Scientific Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.5.5 Eurofins Scientific Recent Development
11.6 Minerva Biolabs
11.6.1 Minerva Biolabs Company Detail
11.6.2 Minerva Biolabs Business Overview
11.6.3 Minerva Biolabs Mycoplasma Testing in Clinical Introduction
11.6.4 Minerva Biolabs Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.6.5 Minerva Biolabs Recent Development
11.7 Charles River
11.7.1 Charles River Company Detail
11.7.2 Charles River Business Overview
11.7.3 Charles River Mycoplasma Testing in Clinical Introduction
11.7.4 Charles River Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.7.5 Charles River Recent Development
11.8 Clongen Laboratories
11.8.1 Clongen Laboratories Company Detail
11.8.2 Clongen Laboratories Business Overview
11.8.3 Clongen Laboratories Mycoplasma Testing in Clinical Introduction
11.8.4 Clongen Laboratories Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.8.5 Clongen Laboratories Recent Development
11.9 BioFire Diagnostics
11.9.1 BioFire Diagnostics Company Detail
11.9.2 BioFire Diagnostics Business Overview
11.9.3 BioFire Diagnostics Mycoplasma Testing in Clinical Introduction
11.9.4 BioFire Diagnostics Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.9.5 BioFire Diagnostics Recent Development
11.10 PromoCell GmbH
11.10.1 PromoCell GmbH Company Detail
11.10.2 PromoCell GmbH Business Overview
11.10.3 PromoCell GmbH Mycoplasma Testing in Clinical Introduction
11.10.4 PromoCell GmbH Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.10.5 PromoCell GmbH Recent Development
11.11 Lonza
11.11.1 Lonza Company Detail
11.11.2 Lonza Business Overview
11.11.3 Lonza Mycoplasma Testing in Clinical Introduction
11.11.4 Lonza Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.11.5 Lonza Recent Development
11.12 Roche
11.12.1 Roche Company Detail
11.12.2 Roche Business Overview
11.12.3 Roche Mycoplasma Testing in Clinical Introduction
11.12.4 Roche Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.12.5 Roche Recent Development
11.13 Agilent Technologies, Inc.
11.13.1 Agilent Technologies, Inc. Company Detail
11.13.2 Agilent Technologies, Inc. Business Overview
11.13.3 Agilent Technologies, Inc. Mycoplasma Testing in Clinical Introduction
11.13.4 Agilent Technologies, Inc. Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.13.5 Agilent Technologies, Inc. Recent Development
11.14 Liofilchem Srl
11.14.1 Liofilchem Srl Company Detail
11.14.2 Liofilchem Srl Business Overview
11.14.3 Liofilchem Srl Mycoplasma Testing in Clinical Introduction
11.14.4 Liofilchem Srl Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.14.5 Liofilchem Srl Recent Development
11.15 ZEAKON Diagnostics
11.15.1 ZEAKON Diagnostics Company Detail
11.15.2 ZEAKON Diagnostics Business Overview
11.15.3 ZEAKON Diagnostics Mycoplasma Testing in Clinical Introduction
11.15.4 ZEAKON Diagnostics Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.15.5 ZEAKON Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Mycoplasma Testing in Clinical Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of PCR
Table 3. Key Players of ELSA
Table 4. Key Players of Enzymatic Methods
Table 5. Key Players of DNA Staining
Table 6. Global Mycoplasma Testing in Clinical Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Mycoplasma Testing in Clinical Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Mycoplasma Testing in Clinical Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Mycoplasma Testing in Clinical Market Share by Region (2019-2024)
Table 10. Global Mycoplasma Testing in Clinical Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Mycoplasma Testing in Clinical Market Share by Region (2025-2030)
Table 12. Mycoplasma Testing in Clinical Market Trends
Table 13. Mycoplasma Testing in Clinical Market Drivers
Table 14. Mycoplasma Testing in Clinical Market Challenges
Table 15. Mycoplasma Testing in Clinical Market Restraints
Table 16. Global Mycoplasma Testing in Clinical Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Mycoplasma Testing in Clinical Market Share by Players (2019-2024)
Table 18. Global Top Mycoplasma Testing in Clinical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Testing in Clinical as of 2023)
Table 19. Ranking of Global Top Mycoplasma Testing in Clinical Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Mycoplasma Testing in Clinical Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Mycoplasma Testing in Clinical Product Solution and Service
Table 23. Date of Enter into Mycoplasma Testing in Clinical Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mycoplasma Testing in Clinical Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Mycoplasma Testing in Clinical Revenue Market Share by Type (2019-2024)
Table 27. Global Mycoplasma Testing in Clinical Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Mycoplasma Testing in Clinical Revenue Market Share by Type (2025-2030)
Table 29. Global Mycoplasma Testing in Clinical Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Mycoplasma Testing in Clinical Revenue Market Share by Application (2019-2024)
Table 31. Global Mycoplasma Testing in Clinical Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Mycoplasma Testing in Clinical Revenue Market Share by Application (2025-2030)
Table 33. North America Mycoplasma Testing in Clinical Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Mycoplasma Testing in Clinical Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Mycoplasma Testing in Clinical Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Mycoplasma Testing in Clinical Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Mycoplasma Testing in Clinical Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Mycoplasma Testing in Clinical Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Mycoplasma Testing in Clinical Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Mycoplasma Testing in Clinical Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Mycoplasma Testing in Clinical Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Mycoplasma Testing in Clinical Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Mycoplasma Testing in Clinical Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Mycoplasma Testing in Clinical Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Mycoplasma Testing in Clinical Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Mycoplasma Testing in Clinical Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Mycoplasma Testing in Clinical Market Size by Country (2025-2030) & (US$ Million)
Table 48. Sartorius AG Company Detail
Table 49. Sartorius AG Business Overview
Table 50. Sartorius AG Mycoplasma Testing in Clinical Product
Table 51. Sartorius AG Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 52. Sartorius AG Recent Development
Table 53. MERCK KGAA Company Detail
Table 54. MERCK KGAA Business Overview
Table 55. MERCK KGAA Mycoplasma Testing in Clinical Product
Table 56. MERCK KGAA Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 57. MERCK KGAA Recent Development
Table 58. ELITechGROUP Company Detail
Table 59. ELITechGROUP Business Overview
Table 60. ELITechGROUP Mycoplasma Testing in Clinical Product
Table 61. ELITechGROUP Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 62. ELITechGROUP Recent Development
Table 63. Bio-Rad Laboratories, Inc. Company Detail
Table 64. Bio-Rad Laboratories, Inc. Business Overview
Table 65. Bio-Rad Laboratories, Inc. Mycoplasma Testing in Clinical Product
Table 66. Bio-Rad Laboratories, Inc. Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 67. Bio-Rad Laboratories, Inc. Recent Development
Table 68. Eurofins Scientific Company Detail
Table 69. Eurofins Scientific Business Overview
Table 70. Eurofins Scientific Mycoplasma Testing in Clinical Product
Table 71. Eurofins Scientific Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 72. Eurofins Scientific Recent Development
Table 73. Minerva Biolabs Company Detail
Table 74. Minerva Biolabs Business Overview
Table 75. Minerva Biolabs Mycoplasma Testing in Clinical Product
Table 76. Minerva Biolabs Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 77. Minerva Biolabs Recent Development
Table 78. Charles River Company Detail
Table 79. Charles River Business Overview
Table 80. Charles River Mycoplasma Testing in Clinical Product
Table 81. Charles River Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 82. Charles River Recent Development
Table 83. Clongen Laboratories Company Detail
Table 84. Clongen Laboratories Business Overview
Table 85. Clongen Laboratories Mycoplasma Testing in Clinical Product
Table 86. Clongen Laboratories Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 87. Clongen Laboratories Recent Development
Table 88. BioFire Diagnostics Company Detail
Table 89. BioFire Diagnostics Business Overview
Table 90. BioFire Diagnostics Mycoplasma Testing in Clinical Product
Table 91. BioFire Diagnostics Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 92. BioFire Diagnostics Recent Development
Table 93. PromoCell GmbH Company Detail
Table 94. PromoCell GmbH Business Overview
Table 95. PromoCell GmbH Mycoplasma Testing in Clinical Product
Table 96. PromoCell GmbH Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 97. PromoCell GmbH Recent Development
Table 98. Lonza Company Detail
Table 99. Lonza Business Overview
Table 100. Lonza Mycoplasma Testing in Clinical Product
Table 101. Lonza Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 102. Lonza Recent Development
Table 103. Roche Company Detail
Table 104. Roche Business Overview
Table 105. Roche Mycoplasma Testing in Clinical Product
Table 106. Roche Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 107. Roche Recent Development
Table 108. Agilent Technologies, Inc. Company Detail
Table 109. Agilent Technologies, Inc. Business Overview
Table 110. Agilent Technologies, Inc. Mycoplasma Testing in Clinical Product
Table 111. Agilent Technologies, Inc. Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 112. Agilent Technologies, Inc. Recent Development
Table 113. Liofilchem Srl Company Detail
Table 114. Liofilchem Srl Business Overview
Table 115. Liofilchem Srl Mycoplasma Testing in Clinical Product
Table 116. Liofilchem Srl Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 117. Liofilchem Srl Recent Development
Table 118. ZEAKON Diagnostics Company Detail
Table 119. ZEAKON Diagnostics Business Overview
Table 120. ZEAKON Diagnostics Mycoplasma Testing in Clinical Product
Table 121. ZEAKON Diagnostics Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
Table 122. ZEAKON Diagnostics Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mycoplasma Testing in Clinical Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Mycoplasma Testing in Clinical Market Share by Type: 2023 VS 2030
Figure 3. PCR Features
Figure 4. ELSA Features
Figure 5. Enzymatic Methods Features
Figure 6. DNA Staining Features
Figure 7. Global Mycoplasma Testing in Clinical Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Mycoplasma Testing in Clinical Market Share by Application: 2023 VS 2030
Figure 9. Cell Line Testing Case Studies
Figure 10. Virus Testing Case Studies
Figure 11. Others Case Studies
Figure 12. Mycoplasma Testing in Clinical Report Years Considered
Figure 13. Global Mycoplasma Testing in Clinical Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Mycoplasma Testing in Clinical Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Mycoplasma Testing in Clinical Market Share by Region: 2023 VS 2030
Figure 16. Global Mycoplasma Testing in Clinical Market Share by Players in 2023
Figure 17. Global Top Mycoplasma Testing in Clinical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Testing in Clinical as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Mycoplasma Testing in Clinical Revenue in 2023
Figure 19. North America Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Mycoplasma Testing in Clinical Market Share by Country (2019-2030)
Figure 21. United States Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Mycoplasma Testing in Clinical Market Share by Country (2019-2030)
Figure 25. Germany Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Mycoplasma Testing in Clinical Market Share by Region (2019-2030)
Figure 33. China Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Mycoplasma Testing in Clinical Market Share by Country (2019-2030)
Figure 41. Mexico Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Mycoplasma Testing in Clinical Market Share by Country (2019-2030)
Figure 45. Turkey Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Sartorius AG Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 48. MERCK KGAA Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 49. ELITechGROUP Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 50. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 51. Eurofins Scientific Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 52. Minerva Biolabs Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 53. Charles River Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 54. Clongen Laboratories Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 55. BioFire Diagnostics Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 56. PromoCell GmbH Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 57. Lonza Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 58. Roche Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 59. Agilent Technologies, Inc. Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 60. Liofilchem Srl Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 61. ZEAKON Diagnostics Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
